M. Awad

Cyclin D1 expression in B-cell non Hodgkin lymphoma

S. Aref, Y. Mossad, T. Elkhodary, 2006 .

CD1 expression in psoriatic and rheumatoid arthritis.

M. Awad, G. Panayi, C. Pitzalis, 2000, Rheumatology.

Monoclonal B-Cell Lymphocytosis Among Egyptian Elderly Healthy Adults

M. Awad, A. Mansour, Nermeen A. Niazy, 2016 .

1173P Early safety, tolerability, and efficacy of REGN5093 in patients (pts) with MET-altered advanced non-small cell lung cancer (aNSCLC) from a first in human (FIH) study

A. Drilon, M. Awad, J. Gray, 2022, Annals of Oncology.

Molecular markers of metastatic disease in KRAS mutant lung adenocarcinoma.

E. V. Van Allen, P. Janne, D. Barbie, 2023, Annals of oncology : official journal of the European Society for Medical Oncology.

453O DS-7300 (B7-H3 DXd antibody-drug conjugate [ADC]) shows durable antitumor activity in advanced solid tumors: Extended follow-up of a phase I/II study

S. Piha-Paul, Shin-ichiro Takahashi, M. Awad, 2022, Annals of Oncology.

989P Sotorasib in advanced KRAS p.G12C-mutated non-small cell lung cancer (NSCLC): Safety and efficacy data from the global expanded access program (EAP)

M. Awad, J. Stevenson, J. Bauman, 2022, Annals of Oncology.

84O Neoadjuvant nivolumab (N) + platinum-doublet chemotherapy (C) for resectable NSCLC: 3-y update from CheckMate 816

S. Broderick, T. Mitsudomi, J. Neely, 2023, Journal of Thoracic Oncology.

Cyclin Dl expression in B-cell non Hodgkin lymphoma.

S. Aref, Y. Mossad, M. Awad, 2006, Hematology.